These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 32058605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD.
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [Abstract] [Full Text] [Related]

  • 5. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.
    Lenartova A, Johannesen TB, Tjønnfjord GE.
    Cancer Med; 2016 Dec; 5(12):3588-3595. PubMed ID: 27925456
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study.
    da Cunha-Bang C, Rostgaard K, Andersen MA, Rotbain EC, Grønbaek K, Frederiksen H, Niemann CU, Hjalgrim H.
    Br J Haematol; 2021 Apr; 193(2):339-345. PubMed ID: 33570184
    [Abstract] [Full Text] [Related]

  • 8. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA.
    J Clin Oncol; 2002 Sep 15; 20(18):3878-84. PubMed ID: 12228208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating MJ.
    Leukemia; 1994 Dec 15; 8(12):2047-51. PubMed ID: 7807993
    [Abstract] [Full Text] [Related]

  • 11. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
    Niparuck P, Kanoksil W, Chuncharunee S, Boonsakan P, Ungkanont A, Angchaisuksiri P, Karntisaviwat K, Apilugsanachit A, Rerkamnuatchoke B, Jootar S, Nitiyanant P, Atichartakarn V.
    Leuk Lymphoma; 2010 Nov 15; 51(11):2120-5. PubMed ID: 20846095
    [No Abstract] [Full Text] [Related]

  • 12. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
    Tietsche de Moraes Hungria V, Chiattone C, Pavlovsky M, Abenoza LM, Agreda GP, Armenta J, Arrais C, Avendaño Flores O, Barroso F, Basquiera AL, Cao C, Cugliari MS, Enrico A, Foggliatto LM, Galvez KM, Gomez D, Gomez A, de Iracema D, Farias D, Lopez L, Mantilla WA, Martínez D, Mela MJ, Miguel CE, Ovilla R, Palmer L, Pavlovsky C, Ramos C, Remaggi G, Santucci R, Schusterschitz S, Sossa CL, Tuna-Aguilar E, Vela J, Santos T, de la Mora O, Machnicki G, Fernandez M, Barreyro P.
    J Glob Oncol; 2019 Nov 15; 5():1-19. PubMed ID: 31774711
    [Abstract] [Full Text] [Related]

  • 13. Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyond.
    Harrop S, Polliack A, Tam CS.
    Leuk Lymphoma; 2021 Apr 15; 62(4):771-778. PubMed ID: 33222561
    [Abstract] [Full Text] [Related]

  • 14. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
    Ailawadhi S, Ravelo A, Ng CD, Shah B, Lamarre N, Wang R, Eakle K, Biondo JM.
    J Comp Eff Res; 2024 Feb 15; 13(2):e230119. PubMed ID: 38294335
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.
    Mauro FR, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E, Sala R, Cerretti R, Mandelli F.
    Blood; 1999 Jul 15; 94(2):448-54. PubMed ID: 10397712
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
    Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP.
    BMC Cancer; 2017 Mar 16; 17(1):198. PubMed ID: 28302090
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study.
    Beiggi S, Johnston JB, Seftel MD, Pitz MW, Kumar R, Banerji V, Griffith EJ, Gibson SB.
    Br J Cancer; 2013 Sep 03; 109(5):1287-90. PubMed ID: 23860531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.